跳至主要内容
临床试验/CTRI/2023/02/049413
CTRI/2023/02/049413尚未招募未知

To evaluate the efficacy of unani formulation (nuskha-e-munzij) along with Hijama-bil-shart (wet cupping) in patients of Rheumatoid Arthritis (Waja-ál-Mafasil) as an adjuvant therapy

Department of Ilaj-bit-Tadbeer, Faculty of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having mild to moderate signs and symptoms of RA (e.g. pain, swelling, stiffness, restricted movements) having score of 6-8 according to the American college of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) 2010, determined on the basis of severity of disease.
  • 2. Patients who have agreed to sign the inform consent form and follow up the protocol

排除标准

  • 1.Recent history of Trauma or fracture of bone.
  • 2.Systemic diseases (e.g, Diabetes and Hypertension).
  • 3.Pregnancy and Lactation.
  • 4.Patients having bleeding disorders.
  • 5.Patients on anti-coagulant and anti-platelet therapy.
  • 6.Angina/MI pain.
  • 7.Cardiopulmonary diseases.
  • 8.Patients of RA with extra articular complications.
  • 9.Advance stage of RA.

研究者

发起方
Department of Ilaj-bit-Tadbeer, Faculty of Unani Medicine

相似试验